David E. Golan, MD, PhD

David Golan, the George R. Minot Professor of Medicine at Harvard Medical School, was appointed dean for research initiatives and global programs in August 2019. He previously served for 11 years as HMS dean for basic science and graduate education and special advisor for global programs. He is a professor in the Department of Biological Chemistry and Molecular Pharmacology, where his laboratory applies biophysical and cell-imaging methods to the study of membrane proteins in blood cells. Dr. Golan is a senior physician in the Department of Medicine at Brigham and Women’s Hospital and Dana-Farber Cancer Institute, where he sees patients as a practicing hematologist and clinician teacher. Dr. Golan founded and directed the core course in pharmacology in the New Pathway curriculum at HMS from 1989 to 2006, and he co-directs a translational pharmacology course that brings together PhD students in the Therapeutics Graduate Program with MD fellows in the Master of Medical Sciences Program in Clinical Investigation at HMS. He is editor-in-chief of Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy, an award-winning textbook of pharmacology that is used worldwide. In his role as dean for research initiatives and global programs, Dr. Golan is responsible for planning, coordination, and operations involving research in the School’s basic and social science departments and for planning, implementation and oversight of interdisciplinary, interdepartmental, School-wide, interinstitutional and global research initiatives and technology platforms at HMS.